COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

Background: Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Breast cancer patients seem to have better prognosis when infected by SARS-CoV-2 than other cancer patients. Methods: We report a subanalysis of the OnCovid study providing more de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laia Garrigós, Cristina Saura, Clara Martinez-Vila, Alberto Zambelli, Mark Bower, Barbara Pistilli, Matteo Lambertini, Diego Ottaviani, Nikolaos Diamantis, Ailsa Lumsden, Sonia Pernas, Daniele Generali, Elia Seguí, Gemma Viñas, Eudald Felip, Ana Sanchez, Gianpiero Rizzo, Armando Santoro, Alessio Cortellini, Ylenia Perone, John Chester, Maria Iglesias, Marta Betti, Bruno Vincenzi, Michela Libertini, Francesca Mazzoni, Federica Zoratto, Rossana Berardi, Annalisa Guida, Rachel Wuerstlein, Angela Loizidou, Rachel Sharkey, Juan Aguilar Company, Marta Matas, Chiara Saggia, Lorenzo Chiudinelli, Emeline Colomba-Blameble, Myria Galazi, Uma Mukherjee, Mieke Van Hemelrijck, Mar Marin, Carla Strina, Aleix Prat, Helena Pla, Eva Maria Ciruelos, Alexia Bertuzzi, Lucia del Mastro, Giampiero Porzio, Thomas Newsom-Davis, Isabel Ruiz, Maria Belen Delany, Marco Krengli, Vittoria Fotia, Alessandro Viansone, Neha Chopra, Margarita Romeo, Ramon Salazar, Ignacio Perez, Francesca d’Avanzo, Michela Franchi, Manuela Milani, Fanny Pommeret, Marco Tucci, Paolo Pedrazzoli, Nadia Harbeck, Daniela Ferrante, David J. Pinato, Alessandra Gennari
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/b31f994a0fcd4f9381a3a63cd473505b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b31f994a0fcd4f9381a3a63cd473505b
record_format dspace
spelling oai:doaj.org-article:b31f994a0fcd4f9381a3a63cd473505b2021-11-03T22:04:01ZCOVID-19 in breast cancer patients: a subanalysis of the OnCovid registry1758-835910.1177/17588359211053416https://doaj.org/article/b31f994a0fcd4f9381a3a63cd473505b2021-11-01T00:00:00Zhttps://doi.org/10.1177/17588359211053416https://doaj.org/toc/1758-8359Background: Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Breast cancer patients seem to have better prognosis when infected by SARS-CoV-2 than other cancer patients. Methods: We report a subanalysis of the OnCovid study providing more detailed information in the breast cancer population. Results: We included 495 breast cancer patients with a SARS-CoV-2 infection. Mean age was 62.6 years; 31.5% presented more than one comorbidity. The most frequent breast cancer subtype was luminal-like ( n  = 245, 49.5%) and 177 (35.8%) had metastatic disease. A total of 332 (67.1%) patients were receiving active treatment, with radical intent in 232 (47.6%) of them. Hospitalization rate was 58.2% and all-cause mortality rate was 20.3%. One hundred twenty-nine (26.1%) patients developed one COVID-19 complication, being acute respiratory failure the most common ( n  = 74, 15.0%). In the multivariable analysis, age older than 70 years, presence of COVID-19 complications, and metastatic disease were factors correlated with worse outcomes, while ongoing anticancer therapy at time of COVID-19 diagnosis appeared to be a protective factor. No particular oncological treatment was related to higher risk of complications. In the context of SARS-CoV-2 infection, 73 (18.3%) patients had some kind of modification on their oncologic treatment. At the first oncological reassessment (median time: 46.9 days ± 36.7), 255 (51.6%) patients reported to be fully recovered from the infection. There were 39 patients (7.9%) with long-term SARS-CoV-2-related complications. Conclusion: In the context of COVID-19, our data confirm that breast cancer patients appear to have lower complications and mortality rate than expected in other cancer populations. Most breast cancer patients can be safely treated for their neoplasm during SARS-CoV-2 pandemic. Oncological treatment has no impact on the risk of SARS-CoV-2 complications, and, especially in the curative setting, the treatment should be modified as little as possible.Laia GarrigósCristina SauraClara Martinez-VilaAlberto ZambelliMark BowerBarbara PistilliMatteo LambertiniDiego OttavianiNikolaos DiamantisAilsa LumsdenSonia PernasDaniele GeneraliElia SeguíGemma ViñasEudald FelipAna SanchezGianpiero RizzoArmando SantoroAlessio CortelliniYlenia PeroneJohn ChesterMaria IglesiasMarta BettiBruno VincenziMichela LibertiniFrancesca MazzoniFederica ZorattoRossana BerardiAnnalisa GuidaRachel WuerstleinAngela LoizidouRachel SharkeyJuan Aguilar CompanyMarta MatasChiara SaggiaLorenzo ChiudinelliEmeline Colomba-BlamebleMyria GalaziUma MukherjeeMieke Van HemelrijckMar MarinCarla StrinaAleix PratHelena PlaEva Maria CiruelosAlexia BertuzziLucia del MastroGiampiero PorzioThomas Newsom-DavisIsabel RuizMaria Belen DelanyMarco KrengliVittoria FotiaAlessandro ViansoneNeha ChopraMargarita RomeoRamon SalazarIgnacio PerezFrancesca d’AvanzoMichela FranchiManuela MilaniFanny PommeretMarco TucciPaolo PedrazzoliNadia HarbeckDaniela FerranteDavid J. PinatoAlessandra GennariSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTherapeutic Advances in Medical Oncology, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Laia Garrigós
Cristina Saura
Clara Martinez-Vila
Alberto Zambelli
Mark Bower
Barbara Pistilli
Matteo Lambertini
Diego Ottaviani
Nikolaos Diamantis
Ailsa Lumsden
Sonia Pernas
Daniele Generali
Elia Seguí
Gemma Viñas
Eudald Felip
Ana Sanchez
Gianpiero Rizzo
Armando Santoro
Alessio Cortellini
Ylenia Perone
John Chester
Maria Iglesias
Marta Betti
Bruno Vincenzi
Michela Libertini
Francesca Mazzoni
Federica Zoratto
Rossana Berardi
Annalisa Guida
Rachel Wuerstlein
Angela Loizidou
Rachel Sharkey
Juan Aguilar Company
Marta Matas
Chiara Saggia
Lorenzo Chiudinelli
Emeline Colomba-Blameble
Myria Galazi
Uma Mukherjee
Mieke Van Hemelrijck
Mar Marin
Carla Strina
Aleix Prat
Helena Pla
Eva Maria Ciruelos
Alexia Bertuzzi
Lucia del Mastro
Giampiero Porzio
Thomas Newsom-Davis
Isabel Ruiz
Maria Belen Delany
Marco Krengli
Vittoria Fotia
Alessandro Viansone
Neha Chopra
Margarita Romeo
Ramon Salazar
Ignacio Perez
Francesca d’Avanzo
Michela Franchi
Manuela Milani
Fanny Pommeret
Marco Tucci
Paolo Pedrazzoli
Nadia Harbeck
Daniela Ferrante
David J. Pinato
Alessandra Gennari
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
description Background: Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Breast cancer patients seem to have better prognosis when infected by SARS-CoV-2 than other cancer patients. Methods: We report a subanalysis of the OnCovid study providing more detailed information in the breast cancer population. Results: We included 495 breast cancer patients with a SARS-CoV-2 infection. Mean age was 62.6 years; 31.5% presented more than one comorbidity. The most frequent breast cancer subtype was luminal-like ( n  = 245, 49.5%) and 177 (35.8%) had metastatic disease. A total of 332 (67.1%) patients were receiving active treatment, with radical intent in 232 (47.6%) of them. Hospitalization rate was 58.2% and all-cause mortality rate was 20.3%. One hundred twenty-nine (26.1%) patients developed one COVID-19 complication, being acute respiratory failure the most common ( n  = 74, 15.0%). In the multivariable analysis, age older than 70 years, presence of COVID-19 complications, and metastatic disease were factors correlated with worse outcomes, while ongoing anticancer therapy at time of COVID-19 diagnosis appeared to be a protective factor. No particular oncological treatment was related to higher risk of complications. In the context of SARS-CoV-2 infection, 73 (18.3%) patients had some kind of modification on their oncologic treatment. At the first oncological reassessment (median time: 46.9 days ± 36.7), 255 (51.6%) patients reported to be fully recovered from the infection. There were 39 patients (7.9%) with long-term SARS-CoV-2-related complications. Conclusion: In the context of COVID-19, our data confirm that breast cancer patients appear to have lower complications and mortality rate than expected in other cancer populations. Most breast cancer patients can be safely treated for their neoplasm during SARS-CoV-2 pandemic. Oncological treatment has no impact on the risk of SARS-CoV-2 complications, and, especially in the curative setting, the treatment should be modified as little as possible.
format article
author Laia Garrigós
Cristina Saura
Clara Martinez-Vila
Alberto Zambelli
Mark Bower
Barbara Pistilli
Matteo Lambertini
Diego Ottaviani
Nikolaos Diamantis
Ailsa Lumsden
Sonia Pernas
Daniele Generali
Elia Seguí
Gemma Viñas
Eudald Felip
Ana Sanchez
Gianpiero Rizzo
Armando Santoro
Alessio Cortellini
Ylenia Perone
John Chester
Maria Iglesias
Marta Betti
Bruno Vincenzi
Michela Libertini
Francesca Mazzoni
Federica Zoratto
Rossana Berardi
Annalisa Guida
Rachel Wuerstlein
Angela Loizidou
Rachel Sharkey
Juan Aguilar Company
Marta Matas
Chiara Saggia
Lorenzo Chiudinelli
Emeline Colomba-Blameble
Myria Galazi
Uma Mukherjee
Mieke Van Hemelrijck
Mar Marin
Carla Strina
Aleix Prat
Helena Pla
Eva Maria Ciruelos
Alexia Bertuzzi
Lucia del Mastro
Giampiero Porzio
Thomas Newsom-Davis
Isabel Ruiz
Maria Belen Delany
Marco Krengli
Vittoria Fotia
Alessandro Viansone
Neha Chopra
Margarita Romeo
Ramon Salazar
Ignacio Perez
Francesca d’Avanzo
Michela Franchi
Manuela Milani
Fanny Pommeret
Marco Tucci
Paolo Pedrazzoli
Nadia Harbeck
Daniela Ferrante
David J. Pinato
Alessandra Gennari
author_facet Laia Garrigós
Cristina Saura
Clara Martinez-Vila
Alberto Zambelli
Mark Bower
Barbara Pistilli
Matteo Lambertini
Diego Ottaviani
Nikolaos Diamantis
Ailsa Lumsden
Sonia Pernas
Daniele Generali
Elia Seguí
Gemma Viñas
Eudald Felip
Ana Sanchez
Gianpiero Rizzo
Armando Santoro
Alessio Cortellini
Ylenia Perone
John Chester
Maria Iglesias
Marta Betti
Bruno Vincenzi
Michela Libertini
Francesca Mazzoni
Federica Zoratto
Rossana Berardi
Annalisa Guida
Rachel Wuerstlein
Angela Loizidou
Rachel Sharkey
Juan Aguilar Company
Marta Matas
Chiara Saggia
Lorenzo Chiudinelli
Emeline Colomba-Blameble
Myria Galazi
Uma Mukherjee
Mieke Van Hemelrijck
Mar Marin
Carla Strina
Aleix Prat
Helena Pla
Eva Maria Ciruelos
Alexia Bertuzzi
Lucia del Mastro
Giampiero Porzio
Thomas Newsom-Davis
Isabel Ruiz
Maria Belen Delany
Marco Krengli
Vittoria Fotia
Alessandro Viansone
Neha Chopra
Margarita Romeo
Ramon Salazar
Ignacio Perez
Francesca d’Avanzo
Michela Franchi
Manuela Milani
Fanny Pommeret
Marco Tucci
Paolo Pedrazzoli
Nadia Harbeck
Daniela Ferrante
David J. Pinato
Alessandra Gennari
author_sort Laia Garrigós
title COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
title_short COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
title_full COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
title_fullStr COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
title_full_unstemmed COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
title_sort covid-19 in breast cancer patients: a subanalysis of the oncovid registry
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/b31f994a0fcd4f9381a3a63cd473505b
work_keys_str_mv AT laiagarrigos covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT cristinasaura covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT claramartinezvila covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT albertozambelli covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT markbower covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT barbarapistilli covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT matteolambertini covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT diegoottaviani covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT nikolaosdiamantis covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT ailsalumsden covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT soniapernas covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT danielegenerali covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT eliasegui covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT gemmavinas covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT eudaldfelip covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT anasanchez covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT gianpierorizzo covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT armandosantoro covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT alessiocortellini covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT yleniaperone covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT johnchester covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT mariaiglesias covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT martabetti covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT brunovincenzi covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT michelalibertini covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT francescamazzoni covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT federicazoratto covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT rossanaberardi covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT annalisaguida covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT rachelwuerstlein covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT angelaloizidou covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT rachelsharkey covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT juanaguilarcompany covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT martamatas covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT chiarasaggia covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT lorenzochiudinelli covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT emelinecolombablameble covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT myriagalazi covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT umamukherjee covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT miekevanhemelrijck covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT marmarin covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT carlastrina covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT aleixprat covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT helenapla covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT evamariaciruelos covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT alexiabertuzzi covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT luciadelmastro covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT giampieroporzio covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT thomasnewsomdavis covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT isabelruiz covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT mariabelendelany covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT marcokrengli covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT vittoriafotia covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT alessandroviansone covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT nehachopra covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT margaritaromeo covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT ramonsalazar covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT ignacioperez covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT francescadavanzo covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT michelafranchi covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT manuelamilani covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT fannypommeret covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT marcotucci covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT paolopedrazzoli covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT nadiaharbeck covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT danielaferrante covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT davidjpinato covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
AT alessandragennari covid19inbreastcancerpatientsasubanalysisoftheoncovidregistry
_version_ 1718445353657696256